AI
Thursday, July 08, 2004 4:16:38 PM
<<I never really considered follow-on trials of a marketed drug to be under the "pipeline" umbrella.>>
PGS, unless there's already broad off label use, e.g. I dunno all the hosts of approved antidepressant studies, I disagree. I think this esp will be true with targeted cancer therapies across different tumor types. I think they need to be looked at under the pipeline umbrella or call it franchise expansion
PGS, unless there's already broad off label use, e.g. I dunno all the hosts of approved antidepressant studies, I disagree. I think this esp will be true with targeted cancer therapies across different tumor types. I think they need to be looked at under the pipeline umbrella or call it franchise expansion
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
